Frontiers in Psychiatry (Jun 2010)
Determination of methylated CpG sites in the promoter region of catechol-O-methyltransferase (<i>COMT</i>) and their involvement in the etiology of tobacco smoking
Abstract
We previously reported that catechol-O-methyltransferase (COMT) is significantly associated with nicotine dependence (ND) in humans. In this study, we examined whether there exists any difference in the extent of methylation of CpG dinucleotides in the promoter region of COMT in smokers and nonsmokers by analyzing the methylation status of cytosines at 33 CpG sites through direct sequencing of bisulfite-treated DNA (N = 50 per group). The cytosine was methylated at 13 of 33 CpG sites, and two of these sites showed significant differences between smokers and matched nonsmoker controls. Specifically, in the -193 CpG site, the degree of methylation was 19.1% in smokers and 13.2% in nonsmokers (P < 0.01). This finding was confirmed by methylation-specific PCR using an additional 100 smoker and 100 nonsmoker control samples, which showed the degree of methylation to be 22.2% in smokers and 18.3% in nonsmokers (P < 0.01). For the -39 CpG site, the degree of methylation was 9.2% in smokers, whereas no methylation was found in nonsmoker controls. Together, our findings provide the first molecular explanation at the epigenetic level for the association of ND with methylation of the COMT promoter, implying that methylation plays a role in smoking dependence.
Keywords
